GPC3 Inhibitors

Chemical inhibitors of Glypican 3 (GPC3) operate through various biochemical mechanisms to inhibit its function. Suramin, for instance, is known to antagonize interactions between heparan sulfate proteoglycans (like GPC3) and growth factors by binding to the heparan sulfate chains. This binding action of suramin can disrupt the functional role of GPC3 in modulating growth factor signaling. Similarly, PI-88, or Muparfostat, which is a heparanase inhibitor, competes with heparan sulfate binding. By inhibiting the enzyme that degrades heparan sulfate, PI-88 also reduces the ability of GPC3 to interact with its ligands, impeding its regulatory functions. Heparin, a highly sulfated glycosaminoglycan, can bind growth factors and potentially impede their interaction with GPC3, through competitive inhibition, thus reducing the signaling capabilities of GPC3.

Furthermore, the correct sulfation of GPC3 is crucial for its function, and several chemicals target this process. Sodium chlorate acts as an inhibitor of sulfation within the cell, leading to the production of under-sulfated heparan sulfate chains on GPC3 and thus limiting its ability to interact with growth factors. Methylthiouracil indirectly hampers GPC3 function by inhibiting thyroid hormone synthesis, which is necessary for proper proteoglycan sulfation. Quercetin targets sulfotransferases, enzymes responsible for transferring sulfate groups to the heparan sulfate chains attached to GPC3, thereby inhibiting the protein's sulfation and its functional capacity. An NDST-1 inhibitor like M-89 would inhibit the N-deacetylation and N-sulfation of heparan sulfate, thus affecting the sulfation necessary for GPC3's function. Collectively, these chemicals disrupt the interaction of GPC3 with growth factors and other molecules by various means, primarily through the alteration of the structure and sulfation of the heparan sulfate chains that are critical to GPC3's role in cellular signaling.